In contrast, differences in levels of endogenous insulin and the relative timing of skeletal maturation vs disease onset (diagnosis of type 1 diabetes at younger ages may precede accrual of peak bone mass) distinguish type 1 and type 2 diabetes and provide some insights into the relative mechanisms of metabolic effects on the skeleton. This evidence concerns the gene INS and type 2 diabetes mellitus.